CoronaCentral
Dashboard
Trending
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Meta-analysis
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
Mentions
Drugs
Genes or Proteins
Genetic Variation
Locations
Medical Specialties
Prevention Methods
Risk Factors
Species
Symptoms
Test Types
Transmission Types
Vaccine Types
Viral Lineages
FAQs
Feedback
Select virus of interest
Drug Targets
Share
Research discussing potential therapeutic coronavirus targets
Published and Preprint Papers
Filter
Export
Title
Altmetric
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
The SARS-CoV-2 main protease M pro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells.
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.
10
15
20
25
30